CABALETTA BIO, INC.

CABA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $165.1M

Liabilities Breakdown FY2025

Total Liabilities: $53.0M